Yongqian P. Jia

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

The overall study protocol for the West China Bone Health Cohort

The overall study protocol for the West China Bone Health Cohort

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: December 25, 2025

Investigation of the expression and potential mechanistic role of BYSL in acute myeloid leukemia.

Investigation of the expression and potential mechanistic role of BYSL in acute myeloid leukemia.

Journal: Clinical and experimental medicine

Published: October 14, 2025

Splenectomy following rituximab and cyclophosphamide for severe autoimmune hemolytic anemia in pregnancy.

Splenectomy following rituximab and cyclophosphamide for severe autoimmune hemolytic anemia in pregnancy.

Journal: Hematology (Amsterdam, Netherlands)

Published: June 16, 2025

CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared With Denosumab in the Treatment of Bone Disease in Patients With Multiple Myeloma.

CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared With Denosumab in the Treatment of Bone Disease in Patients With Multiple Myeloma.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 28, 2025

Corrigendum to "IFN-γ gene loaded human umbilical mesenchymal stromal cells targeting therapy for Graft-versus-host disease" [Int. J. Pharm. 592 (2021) 120058].

Corrigendum to "IFN-γ gene loaded human umbilical mesenchymal stromal cells targeting therapy for Graft-versus-host disease" [Int. J. Pharm. 592 (2021) 120058].

Journal: International journal of pharmaceutics

Published: February 06, 2025

Development of a mitochondria-related gene signature for prognostic assessment in diffuse large B cell lymphoma.

Development of a mitochondria-related gene signature for prognostic assessment in diffuse large B cell lymphoma.

Journal: Frontiers in oncology

Published: December 10, 2024

The characteristics and prognostic analysis of therapy-related acute myeloid leukemia patients in China.

The characteristics and prognostic analysis of therapy-related acute myeloid leukemia patients in China.

Journal: Science China. Life sciences

Published: November 24, 2024

Establishment and evaluation of an automatic multi?sequence MRI segmentation model of primary central nervous system lymphoma based on the nnU?Net deep learning network method.

Establishment and evaluation of an automatic multi?sequence MRI segmentation model of primary central nervous system lymphoma based on the nnU?Net deep learning network method.

Journal: Oncology letters

Published: November 08, 2024

Sociodemographic disparities in influenza vaccination among older adults in United States.

Sociodemographic disparities in influenza vaccination among older adults in United States.

Journal: Frontiers in public health

Published: August 02, 2024

Standard dose anthracycline plus all-trans retinoic acid and arsenic trioxide as induction chemotherapy significantly reduces early death and relapse for high-risk acute promyelocytic leukemia: a single-center real-world analysis.

Standard dose anthracycline plus all-trans retinoic acid and arsenic trioxide as induction chemotherapy significantly reduces early death and relapse for high-risk acute promyelocytic leukemia: a single-center real-world analysis.

Journal: Therapeutic advances in hematology

Published: July 14, 2024

The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination.

The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination.

Journal: Frontiers in oncology

Published: June 29, 2024

Corrigendum to "IFN-γ gene loaded human umbilical mesenchymal stromal cells targeting therapy for Graft-versus-host disease" [Int. J. Pharm. 592 (2021) 120058].

Corrigendum to "IFN-γ gene loaded human umbilical mesenchymal stromal cells targeting therapy for Graft-versus-host disease" [Int. J. Pharm. 592 (2021) 120058].

Journal: International journal of pharmaceutics

Published: March 25, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026